Suchergebnisse - "Hites, Maya"

PubPharm (9)

1

Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Néant, N. | Lingas, G. | Gaymard, A. | +17

2

Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study

enthalten in: Vaccine | 2023

von Buntinx, E. | Brochado, L. | Borja-Tabora, C. | +16

3

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct) : a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care (London, England) | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +154

4

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE) : a multicentre, double-blind, double-dummy, randomised phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Thompson, G. | Soriano, A. | Cornely, O. | +113

CommentIn: Lancet. 2023 Jan 7;401(10370):3-5. - PMID 36442483

5

Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients : a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Lingas, G. | Néant, N. | Gaymard, A. | +17

6

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy) : a phase 3, randomised, controlled, open-label trial

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +115

CommentIn: Lancet Infect Dis. 2021 Sep 14;:null. - PMID 34534513

7

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

enthalten in: Lancet (London, England) | 2022

von Bravo, L. | Smolenov, I. | Han, H. | +44

CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704

8

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Declercq, J. | Van Damme, K. | De Leeuw, E. | +40

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1353-1354. - PMID 34756179

9

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

1
[1]